The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Margaret E. Brousseau

Jean Mayer-USDA Human Nutrition Research Center on Aging

Tufts University

711 Washington Street

Boston

USA

[email]@*.tufts.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Jean Mayer-USDA Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, USA. 2000 - 2002
  • Lipid Metabolism Laboratory, JM-USDA-Human Nutrition Research Center on Aging at Tufts University and Department of Medicine, New England Medical Center, Boston, USA. 2002
  • JM-USDA-HNRCA at Tufts University, 711 Washington Street, Boston, MA 02111, USA. 2002
  • Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, USA. 2000

References

  1. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Brousseau, M.E., O'Connor, J.J., Ordovas, J.M., Collins, D., Otvos, J.D., Massov, T., McNamara, J.R., Rubins, H.B., Robins, S.J., Schaefer, E.J. Arterioscler. Thromb. Vasc. Biol. (2002) [Pubmed]
  2. New targets for medical treatment of lipid disorders. Brousseau, M.E., Schaefer, E.J. Curr. Atheroscler. Rep (2002) [Pubmed]
  3. HDL Cholesterol - Third Annual International Conference. Metabolic Pathways and Drug Development. 25-26 February 2002, Boston, MA, USA. Brousseau, M.E. IDrugs (2002) [Pubmed]
  4. New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterol. Brousseau, M.E., Schaefer, E.J. Curr. Atheroscler. Rep (2001) [Pubmed]
  5. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Brousseau, M.E., Kauffman, R.D., Herderick, E.E., Demosky, S.J., Evans, W., Marcovina, S., Santamarina-Fojo, S., Brewer, H.B., Hoeg, J.M. Arterioscler. Thromb. Vasc. Biol. (2000) [Pubmed]
  6. Diet and coronary heart disease: clinical trials. Brousseau, M.E., Schaefer, E.J. Curr. Atheroscler. Rep (2000) [Pubmed]
 
WikiGenes - Universities